TRUL Q2 2026 Earnings Report

Page 1

Investors Trulieve Trulieve Reports Second Quarter 2026 Results • Second quarter revenue of $ 271 million , with 60 % gross margin • Cash flow from operations of $ 109 million and free cash flow of $ 74 million * in first half of 2026 • First U.S. Cannabis Company listed on New York Stock Exchange under ticker " TRLV " TALLAHASSEE , Fla . , Aug. 7 , 2026 / PRNewswire / -- Trulieve Cannabis Corp. ( NYSE : TRLV ) ( " Trulieve " or " the Company " ) , a leading and top - performing medical cannabis company in the U.S. , today announced its results for the quarter ended June 30 , 2026 . Results are reported in U.S. dollars and in accordance with U.S. Generally Accepted Accounting Principles ( GAAP ) , unless otherwise indicated . Numbers may not sum perfectly due to rounding . Second quarter 2026 results include both Trulieve and Harvest operations until the deconsolidation of Harvest on June 3 , 2026 , and Trulieve medical only operations for the remainder of June . Q2 2026 Financial and Operational Highlights * • Revenue of $ 271 million , with 94 % of revenue from retail sales . • Achieved gross margin of 60 % , with GAAP gross profit of $ 162 million . • Reported net loss attributable to common shareholders of $ 406 million or $ 2.10 per share , includes $ 407 million impact from the Harvest deconsolidation and equity investment . Adjusted net income of $ 20 million * or $ 0.11 per share , excludes non - recurring charges , asset impairments , disposals , unconsolidated entity , deconsolidation transaction , and discontinued operations . Achieved adjusted EBITDA of $ 98 million * , or 36 % of revenue . • Generated cash flow from operations of $ 53 million and free cash flow of $ 32 million * . • Cash at quarter end was $ 325 million . • ⚫ Filed applications to register state licensed medical marijuana operations with the Drug Enforcement Agency following federal rescheduling of medical marijuana to Schedule III . • Completed deconsolidation of Harvest mixed medical and adult use state operations . • Listed on the New York Stock Exchange under ticker TRLV . Announced share repurchase program up to the lesser of $ 50 million or 8,495,038 subordinate voting shares . Began shipment of medical cannabis products to licensed independent pharmacies in Georgia . • Opened four dispensaries in Belleview , Boca Raton , Lutz , and Tallahassee , Florida . * See " Non - GAAP Financial Measures " below for additional information and a reconciliation to GAAP for Non - GAAP metrics . Recent Developments • Obtained shareholder and Board approval for the concurrent domestication of the Company to Delaware and continuance out of British Columbia . • Commemorated Georgia medical cannabis program expansion on July 1 with new product launches and onsite activations across our dispensary network . • Named to TIME's America's Best Companies 2026 List . • Opened one dispensary in Marco Island , Florida . • Currently operate 207 retail dispensaries and 3.5 million square feet of cultivation and processing capacity in the United States . Management Commentary " We made history this quarter as the first U.S. cannabis company to list on the New York Stock Exchange following rescheduling of medical marijuana , " said Kim Rivers , Trulieve CEO . " With broader cannabis rescheduling and state program expansion in markets like Georgia and Texas on the horizon , Trulieve is well positioned to leverage its scale , financial strength , and branded products to drive future growth . " Financial Highlights * Results of Operations ( Figures in millions except per share data ) Revenue Gross profit For the Three Months Ended SA SA $ 170 CA EA SA SA June 30 , June 30 , % Better / March 31 , % Better / June 30 , For the Six Months Ended June 30 , % Better / 2026 * 2025 $ 271 $ 302 ( Worse ) ( 10 % ) 2026 ( Worse ) 2026 * 2025 ( Worse ) $ 287 ( 6 % ) $ 558 $ 600 ( 7 % ) Gross margin % Operating expenses Operating expenses % 162 60 % 183 ( 11 % ) ( 5 % ) $ 332 $ 366 ( 9 % ) 61 % 59 % 60 % 61 % SA 533 $ 197 % 130 43 % NMF EA $ 134 NMF $ 667 $ 280 ( 138 % ) 47 % 120 % 47 % Net ( loss ) income ** Net ( loss ) income continuing operations $ Adjusted net income ( loss ) $ ( 406 ) $ ( 14 ) NMF ( 405 ) ( 16 ) NMF 20 ( 8 ) NMF SSS 2 NMF $ ( 404 ) $ ( 47 ) NMF 3 NMF $ ( 402 ) $ ( 48 ) NMF 20 1 % $ 41 $ ( 11 ) NMF Diluted shares outstanding 193 191 198 193 191 Diluted EPS continuing operations Adjusted Diluted EPS Adjusted EBITDA SASASA $ ( 2.10 ) $ ( 0.07 ) 0.11 98 SASASA NMF $ 0.02 ( 0.04 ) NMF $ 111 ( 11 % ) SA SA SA 0.10 $ 100 NMF 4 % $ ( 2 % ) SA SEA SA $ ( 2.09 ) $ ( 0.23 ) NMF 0.21 $ ( 0.06 ) NMF $ 198 220 ( 10 % ) Adjusted EBITDA Margin % 36 % 37 % 35 % 36 % 37 % NMF No Meaningful Figure † Q2 : 26 reported results reflect the deconsolidation of Harvest on June 3 , 2026 . * See " Non - GAAP Financial Measures " below for additional information and a reconciliation to GAAP for Non - GAAP metrics . ** Net ( loss ) income attributable to common shareholders which excludes non - controlling interest . Conference Call The Company will host a conference call and live audio webcast on August 7 , 2026 , at 8:30 A.M. Eastern time , to discuss its second quarter 2026 financial results . Interested parties can join the conference call by dialing in as directed below . Please dial in 15 minutes prior to the call . North American toll free : 1-844-824-3830 Passcode : 9497090

Page 2

International: 1-412-542-4136 Passcode: 9497090 A live audio webcast of the conference call will be available at: Trulieve Second Quarter 2026 Results Call A powerpoint presentation and archived replay of the webcast will be available at: https://investors.trulieve.com/events The Company's Form 10-Q for the quarter ended June 30, 2026 will be available on the SEC's website or at https://investors.trulieve.com/quarterly-results. The Company's Management's Discussion and Analysis for the period and theaccompanying ﬁnancial statements and notes will be available under the Company's proﬁle on https://www.sedarplus.ca and on itswebsite at https://investors.trulieve.com/quarterly-results. This news release is not in any way a substitute for reading those ﬁnancialstatements, including the notes to the ﬁnancial statements. Trulieve Cannabis Corp.Condensed Consolidated Balance Sheets (Unaudited)(in millions, except for share data) June 30,2026 December 31,2025ASSETSCurrent Assets:Cash and cash equivalents $ 325.4 $ 255.5Accounts receivable, net 3.9 10.5Inventories 186.9 242.3Income tax receivable 0.2 8.5Notes receivable - current portion, net 0.1 1.2Prepaid expenses 20.7 18.3Other current assets 4.7 25.5Management services agreement receivable, related party 22.9 —Assets associated with discontinued operations — 0.9Total current assets 564.8 562.7Property and equipment, net 584.0 670.4Right of use assets - operating, net 86.1 108.3Right of use assets - ﬁnance, net 54.8 60.0Intangible assets, net 300.4 798.4Goodwill 325.6 483.9Notes receivable, net 0.5 0.5Investment in Harvest 152.5 —Other assets 8.7 10.0Long-term assets associated with discontinued operations — 1.9TOTAL ASSETS $ 2,077.4 $ 2,696.1LIABILITIESCurrent Liabilities:Accounts payable and accrued liabilities $ 61.5 $ 82.7Deferred revenue 7.0 9.6Notes payable - current portion 4.2 4.1Operating lease liabilities - current portion 11.3 13.0Finance lease liabilities - current portion 10.1 10.7Construction ﬁnance liabilities - current portion 0.6 2.4Contingencies 0.3 0.8Liabilities associated with discontinued operations — 3.7Total current liabilities 95.1 126.9Long-Term Liabilities:Notes payable, net 89.4 90.8Private placement notes, net 195.8 136.7Operating lease liabilities 85.8 107.9Finance lease liabilities 59.8 64.1Construction ﬁnance liabilities 120.2 133.8Deferred tax liabilities 57.2 178.0Uncertain tax position liabilities 598.2 668.4Other long-term liabilities 10.0 11.4Long-term liabilities associated with discontinued operations — 34.9TOTAL LIABILITIES $ 1,311.5 $ 1,553.1

Page 3

EQUITYCommon shares, no par value; unlimited shares authorized. 192,382,935, and192,307,145 shares issued and outstanding as of June 30, 2026 and December31, 2025, respectively. $ — $ —Additional paid-in-capital 2,083.2 2,073.4Accumulated deﬁcit (1,315.7) (912.1)Non-controlling interest (1.6) (18.2)TOTAL EQUITY 765.9 1,143.0TOTAL LIABILITIES AND EQUITY $ 2,077.4 $ 2,696.1 Trulieve Cannabis Corp.Condensed Consolidated Statements of Operations (Unaudited)(in millions, except for share data) Three Months EndedJune 30, Six Months EndedJune 30,2026 2025 2026 2025Revenue $ 271.0 $ 302.1 $ 557.7 $ 599.8Cost of goods sold 108.7 119.2 225.3 233.7Gross proﬁt 162.3 182.9 332.4 366.1Expenses:Selling, general, and administrative 101.8 101.1 206.7 219.9Depreciation and amortization 25.7 29.4 55.5 58.8Loss (gain) on disposal or impairment of assets 2.0 (0.3) 1.7 1.5Loss on deconsolidation transaction 403.3 — 403.3 —Total expenses 532.8 130.3 667.2 280.2(Loss) income from operations (370.5) 52.6 (334.8) 86.0Other income (expense):Interest expense, net (12.8) (16.4) (26.1) (32.7)Interest income 3.1 3.6 5.7 6.7Equity in net loss of Harvest (3.3) — (3.3) —Other income (expense), net 0.1 (1.0) 0.2 (0.7)Total other expense, net (12.9) (13.7) (23.4) (26.7)(Loss) income before provision for income taxes (383.4) 38.9 (358.2) 59.2Provision for income taxes 22.0 54.7 43.8 107.2Net loss from continuing operations (405.4) (15.8) (402.0) (48.0)Net loss from discontinued operations, net of tax beneﬁt (provision) of $237,$(441), $597, and $(441) respectively, attributable to common shareholders (0.7) (0.3) (1.8) (1.9)Net loss (406.1) (16.1) (403.8) (49.9)Less: net loss attributable to non-controlling interest from continuing operations (0.1) (2.3) (0.2) (3.2)Net loss attributable to common shareholders $ (406.0) $ (13.8) $ (403.6) $ (46.7) Earnings Per ShareNet loss per share - Continuing operations:Basic and diluted $ (2.10) $ (0.07) $ (2.09) $ (0.23)Net loss per share - Discontinued operations:Basic and diluted $ (0.00) $ (0.00) $ (0.01) $ (0.01)Weighted average number of common shares used in computing net loss per share:Basic and diluted 192.7 191.2 192.6 191.2 Trulieve Cannabis Corp.Condensed Consolidated Statements of Cash Flows (Unaudited)(in millions) Three Months EndedJune 30, Six Months EndedJune 30,2026 2025 2026 2025Cash ﬂows from operating activitiesNet loss $ (406.1) $ (16.1) $ (403.8) $ (49.9)Adjustments to reconcile net loss to net cash provided by operating activities:Depreciation and amortization 25.7 29.4 55.5 58.8Depreciation included in cost of goods sold 13.4 13.7 27.4 27.6Loss on deconsolidation transaction 403.3 — 403.3 —

Page 4

Equity in net loss of Harvest 3.3 — 3.3 —Impairment and disposal of long-lived assets, net of recoveries 2.0 (2.0) 1.7 (0.2)Gain from disposal of discontinued operations — — — —Share-based compensation 6.9 6.8 11.1 10.7Deferred income taxes (10.8) (5.3) (19.1) (9.9)Other non-cash changes 3.5 7.3 6.7 12.3Changes in operating assets and liabilities:Inventories 6.0 (2.2) 6.0 (10.1)Accounts receivable 1.1 (0.8) (2.7) (3.4)Other assets (28.4) 7.0 (30.7) (1.0)Accounts payable and accrued liabilities 5.4 (11.6) (3.4) (11.8)Income tax receivable / payable (0.6) 1.3 1.1 2.7Uncertain tax position liabilities 32.9 58.7 61.0 114.4Other liabilities (4.6) (6.0) (8.5) (8.7)Proceeds received from insurance for operating expenses — 5.7 — 5.7Net cash provided by operating activities 53.1 86.1 108.8 137.2Cash ﬂows from investing activitiesCapital expenditures (21.0) (16.0) (34.5) (36.8)Maturities of short-term investments — — — 60.0Cash disposed in deconsolidation transaction (58.4) — (58.4) —Other proceeds 4.5 7.4 4.8 11.4Other purchases and payments — — — (0.2)Net cash (used in) provided by investing activities (74.9) (8.6) (88.0) 34.4Cash ﬂows from ﬁnancing activitiesProceeds from long-term borrowings — — 60.7 —Payments on long-term borrowings (1.7) (3.6) (3.7) (5.5)Payments for debt issuance costs — — (1.3) —Other payments and distributions (2.8) (2.2) (5.4) (4.6)Payments for taxes related to net share settlement of equity awards (1.3) (0.1) (1.3) (0.3)Net cash provided by (used in) ﬁnancing activities (5.7) (5.8) 49.1 (10.3)Net increase in cash and cash equivalents, and restricted cash (27.5) 71.6 69.9 161.3Cash, cash equivalents, and restricted cash, beginning of period 352.9 329.4 255.5 239.7Cash, cash equivalents, and restricted cash, end of period $ 325.4 $ 401.0 $ 325.4 $ 401.0The condensed consolidated statements of cash ﬂows include continuing operations and discontinued operations for the periodspresented. Non-GAAP Financial Measures (Unaudited) In addition to our results determined in accordance with GAAP, we supplement our results with non-GAAP ﬁnancial measures,including EBITDA, adjusted EBITDA, EBITDA margin, adjusted EBITDA margin, adjusted net income (loss), adjusted net income(loss) per diluted share, and free cash ﬂow. The Company calculates EBITDA as net income (loss) before net interest expense, interest income, income tax expense, depreciationand amortization; adjusted EBITDA as net income (loss) before net interest expense, interest income, income tax expense, depreciationand amortization and also excludes certain extraordinary items; EBITDA margin as EBITDA as % of revenue; adjusted EBITDAmargin as adjusted EBITDA as % of revenue; adjusted net income (loss) as net income (loss) less certain extraordinary items; adjustedEPS as adjusted net income (loss) divided by diluted shares outstanding; and free cash ﬂow as cash ﬂow from operations less capitalexpenditures. Our management uses these non-GAAP ﬁnancial measures in conjunction with GAAP ﬁnancial measures to evaluate our operatingresults and ﬁnancial performance. We believe these measures are useful to investors as they are widely used measures of performanceand can facilitate comparison to other companies. These non-GAAP ﬁnancial measures are not, and should not be considered as,measures of liquidity. These non-GAAP ﬁnancial measures have limitations as analytical tools in that they do not reﬂect all of theamounts associated with our results of operations as determined in accordance with GAAP. Because of these limitations, these non-GAAP ﬁnancial measures should be considered along with GAAP ﬁnancial performance measures. The presentation of these non-GAAP ﬁnancial measures is not intended to be considered in isolation or as a substitute for, or superior to, ﬁnancial informationprepared and presented in accordance with GAAP. Investors are encouraged to review the reconciliation of these non-GAAP ﬁnancialmeasures to their most directly comparable GAAP ﬁnancial measures. A reconciliation of the non-GAAP ﬁnancial measures to suchGAAP measures can be found below. These non-GAAP ﬁnancial measures should be considered supplemental to, and not a substitutefor, our reported ﬁnancial results prepared in accordance with GAAP. Reconciliation of Non-GAAP EBITDA and Adjusted EBITDA (Unaudited) The following table presents a reconciliation of GAAP net (loss) income attributable to common shareholders to non-GAAP EBITDAand Adjusted EBITDA for each of the periods presented: (Amounts expressed in millions of United States dollars) Three Months Ended For the Six Months Ended

Page 5

June 30,2026 June 30,2025 March 31,2026 June 30,2026 June 30,2025Net (loss) income attributable to common shareholders $ (406.0) $ (13.8) $ 2.4 $ (403.6) $ (46.7)Add (deduct) impact of:Interest expense, net $ 12.8 $ 16.4 $ 13.3 $ 26.1 $ 32.7Interest income $ (3.1) $ (3.6) $ (2.7) $ (5.7) $ (6.7)Provision for income taxes $ 22.0 $ 54.7 $ 21.9 $ 43.8 $ 107.2Depreciation and amortization $ 25.7 $ 29.4 $ 29.7 $ 55.5 $ 58.8Depreciation included in cost of goods sold $ 13.4 $ 13.7 $ 14.0 $ 27.4 $ 27.6EBITDA (Non-GAAP) $ (335.2) $ 96.8 $ 78.6 $ (256.5) $ 172.8EBITDA Margin (Non-GAAP) NMF 32 % 27 % NMF 29 % Loss (gain) on disposal or impairment of assets $ 2.0 $ (0.3) $ (0.3) $ 1.7 $ 1.5Campaign and political contributions $ 4.7 $ 4.4 $ 9.5 $ 14.3 $ 27.4Acquisition, transaction, and other non-recurring costs $ 12.3 $ 1.6 $ 7.4 $ 19.8 $ 4.7Share-based compensation $ 6.9 $ 6.8 $ 4.1 $ 11.1 $ 10.7Other (income) expense, net $ (0.1) $ 1.0 $ (0.1) $ (0.2) $ 0.7Equity in net loss of Harvest $ 3.3 $ — $ — $ 3.3 $ —Loss on deconsolidation transaction $ 403.3 $ — $ — $ 403.3 $ —Discontinued operations, net of tax, attributable tocommon shareholders $ 0.7 $ 0.3 $ 1.1 $ 1.8 $ 1.9Adjusted EBITDA (Non-GAAP) $ 98.0 $ 110.6 $ 100.4 $ 198.4 $ 219.8Adjusted EBITDA Margin (Non-GAAP) 36 % 37 % 35 % 36 % 37 %NMF – No Meaningful Figure Reconciliation of Non-GAAP Adjusted Net Income (Loss) (Unaudited) The following table presents a reconciliation of GAAP net (loss) income attributable to common shareholders to non-GAAP adjustednet income (loss), for each of the periods presented: For the Three Months Ended For the Six Months Ended (Amounts expressed in millions of United States dollars) June 30,2026 June 30,2025 March 31,2026 June 30,2026 June 30,2025Net (loss) income attributable to common shareholders $ (406.0) $ (13.8) $ 2.4 $ (403.6) $ (46.7)Net loss from discontinued operations, net of tax,attributable to common shareholders $ 0.7 $ 0.3 $ 1.1 $ 1.8 $ 1.9Net (loss) income from continuing operations available tocommon shareholders $ (405.3) $ (13.5) $ 3.5 $ (401.8) $ (44.7)Add (deduct) impact of:Loss (gain) on disposal or impairment of assets $ 2.0 $ (0.3) $ (0.3) $ 1.7 $ 1.5Campaign and political contributions $ 4.7 $ 4.4 $ 9.5 $ 14.3 $ 27.4Acquisition, transaction, and other non-recurring costs $ 12.3 $ 1.6 $ 7.4 $ 19.8 $ 4.7Equity in net loss of Harvest $ 3.3 $ — $ — $ 3.3 $ —Loss on deconsolidation transaction $ 403.3 $ — $ — $ 403.3 $ —Adjusted net income (loss) (Non-GAAP) $ 20.4 $ (7.7) $ 20.2 $ 40.6 $ (11.1) Reconciliation of Non-GAAP Adjusted Net Income (Loss) Per Diluted Share (Unaudited) The following table presents a reconciliation of GAAP net (loss) income attributable to common shareholders per share to non-GAAPadjusted net income (loss) per diluted share, for each of the periods presented: For the Three Months Ended For the Six Months Ended(Amounts expressed are per share except for shareswhich are in millions) June 30,2026 June 30,2025 March 31,2026 June 30,2026 June 30,2025Net (loss) income attributable to common shareholders $ (2.11) $ (0.07) $ 0.01 $ (2.10) $ (0.24)Net loss from discontinued operations, net of tax,attributable to common shareholders $ 0.00 $ 0.00 $ 0.01 $ 0.01 $ 0.01Net (loss) income from continuing operations available tocommon shareholders $ (2.10) $ (0.07) $ 0.02 $ (2.09) $ (0.23)Add (deduct) impact of:Loss (gain) on disposal or impairment of assets $ 0.01 $ (0.00) $ (0.00) $ 0.01 $ 0.01Campaign and political contributions $ 0.02 $ 0.02 $ 0.05 $ 0.07 $ 0.14Acquisition, transaction, and other non-recurring costs $ 0.06 $ 0.01 $ 0.04 $ 0.10 $ 0.02Equity in net loss of Harvest $ 0.02 $ — $ — $ 0.02 $ —Loss on deconsolidation transaction $ 2.09 $ — $ — $ 2.09 $ —Adjusted net income (loss) (Non-GAAP) $ 0.11 $ (0.04) $ 0.10 $ 0.21 $ (0.06)

Page 6

Diluted shares outstanding 192.7 191.2 197.8 192.6 191.2 Reconciliation of Non-GAAP Free Cash Flow (Unaudited) The following table presents a reconciliation of GAAP cash ﬂow from operating activities to non-GAAP free cash ﬂow, for each of theperiods presented: For the Three Months Ended For the Six Months Ended (Amounts expressed in millions of United States dollars) June 30,2026 June 30,2025 March 31,2026 June 30,2026 June 30,2025Cash ﬂow from operating activities $ 53.1 $ 86.1 $ 55.7 $ 108.8 $ 137.2Capital expenditures $ (21.0) $ (16.0) $ (13.5) $ (34.5) $ (36.8)Free cash ﬂow (Non-GAAP) $ 32.1 $ 70.1 $ 42.2 $ 74.4 $ 100.4 Forward-Looking Statements This news release includes forward-looking information and statements within the meaning of the U.S. Private Securities LitigationReform Act of 1995 and applicable Canadian securities legislation (collectively herein referred to as "forward-looking statements").These forward-looking statements relate to the Company's expectations or forecasts of business, operations, ﬁnancial performance,cash ﬂows, prospects, and other plans, intentions, expectations, estimates, and beliefs and include statements regarding broadercannabis rescheduling and state program expansion. Words such as "expects", "continue", "will", "anticipates" and "intends" or similarexpressions are intended to identify forward-looking statements. These forward-looking statements are based on the Company's currentprojections and expectations about future events and ﬁnancial trends that management believes might affect its ﬁnancial condition,results of operations, business strategy and ﬁnancial needs, and on certain assumptions and analysis made by the Company in light ofthe experience and perception of historical trends, current conditions and expected future developments and other factors managementbelieves are appropriate. Forward-looking statements involve and are subject to assumptions and known and unknown risks,uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materiallydifferent from future events, results, performance, and achievements expressed or implied by forward-looking statements herein,including, without limitation, the risks discussed under the heading "Risk Factors" in our most recent Annual Report on Form 10-K andin our periodic reports subsequently ﬁled with the United States Securities and Exchange Commission and in the Company's ﬁlings onhttps://www.sedarplus.ca. Although the Company believes that any forward-looking statements herein are reasonable, in light of theuse of assumptions and the signiﬁcant risks and uncertainties inherent in such statements, there can be no assurance that any suchforward-looking statements will prove to be accurate, and accordingly readers are advised to rely on their own evaluation of such risksand uncertainties and should not place undue reliance upon such forward-looking statements. Any forward-looking statements hereinare made as of the date hereof and, except as required by applicable laws, the Company assumes no obligation and disclaims anyintention to update or revise any forward-looking statements herein or to update the reasons that actual events or results could or dodiffer from those projected in any forward-looking statements herein, whether as a result of new information, future events or results,or otherwise. About Trulieve Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with established medicalmarijuana operations in Florida, Georgia, Pennsylvania, and West Virginia. Driven by a core mission to expand access to cannabis,Trulieve serves customers with innovative, high-quality branded products and exceptional experiences. With scaled operations inattractive markets and targeted expansion through its hub strategy, Trulieve is poised for accelerated growth. Trulieve is listed on theNYSE under the symbol TRLV. For more information, please visit Trulieve.com. Facebook: @TrulieveInstagram: @TrulieveX: @Trulieve Investor and Media Contact Christine Hersey, Chief Corporate Affairs & Strategy Ofﬁcer+1 (424) 202-0210Christine.Hersey@Trulieve.com SOURCE Trulieve Cannabis Corp. https://investors.trulieve.com/2026-08-07-Trulieve-Reports-Second-Quarter-2026-Results

Earnings release